GAO Blasts FDA on Failing to Inspect Foreign Drug Plants
A new government report finds that the FDA is failing to inspect foreign drug manufacturing plants that may pose the greatest risk to public health if something should go wrong.
Tag Archives: Defective Drug
-
-
Columbia University Brain Imaging Center Problems Result in FDA Warning
Federal inspections have uncovered a number of problems at a brain-imaging center operated by Columbia University, where patients with mental disorders were injected with substandard medications.
-
Contamination Leads to Recall of Intravenous Drugs by Claris
Foreign matter that was found floating in IV bags has led to a recall for ciprofloxacin, metronidazole, and ondansetron manufactured by Claris Lifesciences.
-
Hylenex Recall: Baby Rehydration Fluids Contaminated with Glass Flakes
Baxter International Inc. is recalling about 3,200 vials of Hylenex, a pediatric rehydration medication, due to glass flake contamination. Halozyme Therapeutics, a company partnered with Baxter to manufacture Hylenex, has…
-
FDA Drug Safety Monitoring No Better 3 Years Following Vioxx Recall: Report
A new report by the Government Accountability Office (GAO) indicates that the FDA has made little progress in its oversight of post-market drug safety, despite federal recommendations made in 2006.…
-
FDA Oversight of Unproven Drugs is Lacking: Government Report
A new congressional report from the Government Accountability Office (GAO) indicates that the FDA has failed to follow up on unproven drugs that are put on the market through an…
